Key research themes
1. How is inducible nitric oxide synthase (iNOS) transcriptionally and post-translationally regulated under inflammatory and oxidative stress conditions?
This research area focuses on understanding the molecular mechanisms governing iNOS expression and activity in response to pro-inflammatory stimuli and oxidative milieu. Since iNOS produces high levels of nitric oxide during inflammation, its regulation is critical for balancing protective versus pathological effects in cardiovascular and immune systems. Insights into transcriptional activation pathways (e.g., NF-κB, STAT), redox modulation, and post-translational modifications provide targets for therapeutic modulation.
2. What are the functional roles and pathological implications of iNOS-derived nitric oxide in vascular inflammation, atherogenesis, and cardiovascular disease progression?
This theme investigates how iNOS-produced nitric oxide contributes to vascular pathologies such as atherosclerosis by mediating inflammation, modulating vascular smooth muscle cell behavior, and influencing oxidative stress. Quantifying iNOS expression in vascular tissues and defining its relationship with endothelial dysfunction, inflammation-induced remodeling, and oxidative damage is fundamental for deciphering disease mechanisms and identifying therapeutic intervention points.
3. How do different NOS isoforms, especially iNOS, contribute to pathological processes in non-cardiovascular diseases such as neurodegeneration and diabetes, and what are the implications for therapeutic modulation?
Research in this domain explores the roles of iNOS in neurodegenerative disorders and metabolic diseases, focusing on how aberrant iNOS activation leads to nitrosative stress, neuronal toxicity, and β-cell dysfunction. The investigation into isoform-specific expression patterns, cellular targets, and signaling cascades informs strategies to selectively inhibit pathological NOS activity without disrupting physiological NO signaling, emphasizing the translational potential in treating complex systemic diseases.